Why Lanthanein Resources (ASX:LNR) more than doubled on December 6 2023

Nick Sundich Nick Sundich, December 6, 2023

Lanthanein Resources (ASX:LNR), an ASX small cap explorer focused on rare earths, rose after signing a farm-in agreement, but not the typical kind you may think. Typically farm in agreements involve a major miner coming to the table to prospect at the smaller company’s project. In this instance, it is Lanthanein that has initiated a farm-in agreement, and it also may mark a change in direction for the company.

 

Lanthanein Resources (ASX:LNR) share price chart, log scale (Source: TradingView)

 

Lanthanein Resources pivoting to lithium

Lanthanein told investors it entered into a transaction to earn up to a 70% interest in the Lady Grey Lithium Project. This is 365km east of Perth and is directly adjacent to the nearby Earl Gray Mine. This operation has a resource of 189MT @ 1.53% lithium and is co-operated by SQM and Wesfarmers. And Lanthanein has not just been granted a small tenure, it has obtained 77km with ~18km of strike.

 

So now what?

Lanthanein told investors it would begin a drilling program in the first quarter of next year. It has an approved program for 193 Aircore and 53 RC (Reverse Circulation) drillholes, along with an extensive soil geochemistry program across other targets. There are also heritage approvals for expanded drill programs.

If the program is successful, there could be more upside in this one. However, as it is with all early stage explorers, shareholders can do nothing more at this stage than keep their fingers crossed.

 

What are the Best ASX Stocks to invest in right now?

Check our ASX buy/sell tips

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Trump vs. Jerome Powell

Trump vs. Jerome Powell: What Happens to the Market If Powell Is Fired?

The relationship between President Donald Trump and Federal Reserve Chair Jerome Powell has often been tumultuous, particularly around decisions regarding…

Telix Pharmaceuticals on the Nasdaq

Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!

What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…

anti woke ETFs

Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?

Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…